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Background

Hospital Course

Severe Asthma Exacerbations (SAE) in opiate tolerant
patients merit consideration of non-narcotic sedation
strategies.
• The following case illustrates unique challenges.

• The decision was made to intubate with ketamine
140mg IV and succinylcholine 100mg IV.
• He again received nebulized albuterol 10mg and
magnesium sulfate 2mg IV.
• Initial labs found a leukocytosis of 34.4k cells/uL (n: 512k), lactic acid of 2.9mmol/L (n: .7-2), ABG pH of 7.13
(n: 7.35-7.45) and PaCO2 of 89.9mmHg (n: 35-48).
• Urine drug screen found benzodiazepines, cannabinoids
and opiates.
• He was escalated to vancomycin and
piperacillin/tazobactam for endocarditis concerns.
• His lactic acid trended up to 6.5mmol/L warranting an
additional 2L normal saline IV.
• A chest radiograph, CTA chest and echocardiogram
found no acute pathology.
• He required the maximum dose of fentanyl for sedation.
• On day 2, he was weaned for extubation, but his BP
increased to 190/80mmHg.
• He was started on morphine 2mg IV for concerns of
acute opiate withdrawal, and his BP normalized.
• His sputum culture grew Hemophilus influenzae.
• He was extubated later that day when stable.
• He was counselled extensively on medication
compliance and illicit substance cessation.

•

Case Presentation
HPI: A 24-year-old male with a history of asthma
presented to our ED for acutely worsening shortness of
breath for one hour. He ran out of his inhaler one month
ago after losing his insurance. His girlfriend provided
more history including recent IV heroin use one week
ago and previous intubations for asthma. They denied
any recent fevers, sick contacts, travel, nor vaccinations.
• Pertinent Physical Exam Findings:
o HR 129bpm, BP 147/70mmHg, and SpO2 65% on 10L
NRB mask
o CV: tachycardia, no carotid bruits, no JVD
o Respiratory: supraclavicular retractions, one word
sentences, bilateral inspiratory and expiratory
wheezing
o Skin: diaphoretic, multiple tender lesions on his hands
• EKG: sinus tachycardia without ischemic changes
• ED Course:
o He was advanced to BiPAP
o Blood, urine, and sputum cultures collected
o Given nebulized albuterol 10mg, methylprednisolone
125mg IV, magnesium sulfate 2mg IV,
ampicillin/sulbactam 1.5g IV, and a 1L IV NS bolus
o He continued to decline.
•

Figure 2. Radiographic Progression

Figure 1. Admission ECG
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Discussion
• Expert opinion suggests a potential role for the

•
•

•
•

•

administration of continuous ketamine infusions for
concomitant sedative and bronchodilatory effects in
opiate tolerant patients.
After intubation, our patient received fentanyl and
propofol.
This may have exacerbated his respiratory acidosis,
masked opiate withdrawal symptoms, and complicated
his extubation.
Further research may enable more effective
management of SAE in opiate tolerant patients.
Of note, previous reports correlate albuterol with type B
lactic acidosis that may have played a role in reduced
oxygenation in our patient.
New strategies are needed to manage SAE in opiate
tolerant patients.

References
1. Mehta S, et al. COPD and asthma in patients with opioid dependency. Prim
Care Respir Med. 2020;30(4). doi.org/10.1038/s41533-019-0161-7
2. Lewis LM, Ferguson I, et al. Albuterol administration is associated with
increases in serum lactate in acute exacerbation of asthma. Chest.
2014;145(1):53-9.
3. Levine M, Iliescu ME, et al. The effects of cocaine and heroin use on
intubation rates and hospital in patients with asthma exacerbations. Chest.
2005;128:1951–7.
4. Le Conte P, Terzi N, Mortamet G, et al. Management of severe asthma
exacerbation. Annals of Intensive Care 2019; 9(115). doi.org/10.1186/s13613019-0584-x
5. Hockstein M, Diercks D. Significant Lactic Acidosis from Albuterol. Clin Pract
Cases Emerg Med. 2018;2(2):128-131. doi:10.5811/cpcem.2018.1.36024
6. Krishnan V, Diette GB, Rand CS, et al. Mortality in patients hospitalized for
asthma exacerbations in the United States. Am J Respir Crit Care Med 2006;
174(633).
7. Nanchal R, Kumar G, Majumdar T, et al. Utilization of mechanical ventilation
for asthma exacerbations: analysis of a national database. Respir Care 2014;
59:644.
8. Althoff MD, Holguin F, Yang F, et al. Noninvasive Ventilation Use in Critically
Ill Patients with Acute Asthma Exacerbations. Am J Respir Crit Care Med.
2020; 202:1520.
9. Zitek T, Cleveland N, Rahbar A, et al. Effect of nebulized albuterol on serum
lactate and potassium in healthy subjects. Acad Emerg Med. 2016;23(6):718–
21.
10.Rodrigo GJ, Rodrigo C. Elevated plasma lactate level associated with high
dose inhaled albuterol therapy in acute severe asthma. Emerg Med J.
2005;22(6):404–8.

The authors have
no conflicts of
interest to
disclose.

